Legal Representation
Attorney
Michael R. Graif
USPTO Deadlines
Next Deadline
82 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
November 01, 2025
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 1, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 1, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Aug 1, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Aug 1, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 17, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 17, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 17, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 13, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 13, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Mar 3, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 3, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Sep 4, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Sep 4, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Sep 4, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 6, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 4, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Mar 4, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Mar 4, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jan 4, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 13, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Sep 11, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Sep 11, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 11, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 9, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 8, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 7, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Jun 26, 2023 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Jun 25, 2023 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Jun 25, 2023 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Jun 25, 2023 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Jun 15, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 15, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 15, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 15, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 15, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 5, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jun 5, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 1, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 1, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Sep 6, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Sep 6, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Aug 17, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Aug 1, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 1, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Aug 1, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 1, 2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Aug 1, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Aug 1, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 1, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Detailed Classifications
Class 042
Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the field of cancer and immunological diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Consulting services in the field of pharmaceutical research and development
Additional Information
Pseudo Mark
T BOLT
Classification
International Classes
042